Knowledge Item: CA-Medical Outcomes-12
 Length of Time a Participant is Maintained at the Same or an Improved Quality of Life as a Function of the Type of Medical Project Providing Treatment

This Knowledge Item is a follow-up to Knowledge Item: CA-Quality of Life-50 and Knowledge Item: CA-Quality of Life-51 which also present data on the days that quality of life is maintained for  a third group of projects, Community Based Organizations, that provide psychosocial services with linkages to medical care. This Knowledge Item follows up on the earlier work by explicitly controlling for the clients stage of HIV disease, as measured by a control factor of the earliest known CD4 count, and the classification of factor as to whether the client had an AIDS-defining condition during the course of the treatment episode. Since the CBO projects did not collect data on medical test results or opportunistic infections, their data is not used here. The data from one project (with 38 patients) were not included in these analyses because that project explicitly targeted AIDS patients at the end of their lives by providing home healthcare under a managed care model, and it was believed that the data from that project would skew the results for the Managed Care projects.

The probability of maintaining an individual at or above the baseline Total Quality of Life Score was estimated from a Cox (proportional hazards) regression or survival analysis. Initial levels of quality of life and initial levels of physical functioning (as measured by CD4 count) were controlled.

More than half of the individuals, in this progressive disease, may be maintained at the same or higher quality of life for a period of time approaching the maximum in our evaluation study, of about three years. Different rates of maintaining patients at full, 90%, and 80% quality of life are found for Managed Care projects not utilizing wrap-around psychosocial services and University-based Comprehensive Healthcare programs that do utilize wrap-around psychosocial services.

Further analyses given in Knowledge Items: CA-Quality of Life and Health-37, -42, -43, -50, -51, and -39, as well as Knowledge Items: CA-Medical Outcomes-11 and -13 show additional analyses that confirm that the projects with wrap-around comprehensive psychosocial services, supplementing basic medical services, tend to maintain the patient at the same or an increased quality of life for a longer time, and with a greater ratio of improvement, than just medical services. The additional Knowledge Items use alternate statistical designs and models with different factors "controlled," but the different methods of assessing the relative effectiveness of these different types of service models in achieving improved quality of life for the patients all point out the importance of integrated psychosocial or "wrap-around" services. 



Click graphic to expand. (IE 6 users may also have to click the graphic expansion button in the new window.)
Click graphic to expand. (IE 6 users may also have to click the graphic expansion button in the new window.)


Click graphic to expand. (IE 6 users may also have to click the graphic expansion button in the new window.)
Click graphic to expand. (IE 6 users may also have to click the graphic expansion button in the new window.)

More Information:     CHAID and CHAID Diagram

Note: The CD4 categories used here are based on the 1993 guidelines published in MMWR on December 18, 1992 for the three categories of CD4 of 500 or more, 200 - 499, and less than 200. The latter category has been further differentiated by adding a category of CD4 < 50 because of the clinical utility of this category for clinical decisions (see Bartlett's Medical Management of HIV Infection). The CD4 classifications are based on a test made on the same date; unlike the classifications used in some clinical trials and CDC publications, the values given are not nadir (minimum lifetime) values.

In interpreting this Knowledge Item, and all others in this section on Medical Outcomes, remember that the ratings of quality of life, symptom impact, and healthcare utilization are based on patient self reports unless noted otherwise. 

Knowledge Item Citation: Huba, G. J., Melchior, L. A., Panter, A. T., and the HRSA/HAB SPNS Cooperative Agreement Steering Committee (1998-2001). Knowledge Item: CA-Medical Outcomes-12 from HRSA/HAB's SPNS Cooperative Agreements on Innovative Models of Care, The Measurement Group Knowledge Base on HIV/AIDS Care, Online at www.TheMeasurementGroup.com.

Last Updated: March 25, 2005; data through June 15, 1999; analyses conducted March - November 2000.



Knowledge Base Citation: The Knowledge Base and this Knowledge Item were designed and authored by G. J. Huba, Ph.D.; in collaboration with Lisa A. Melchior, Ph.D.; A. T. Panter, Ph.D.; and the staff of The Measurement Group. Cite this work as "Huba, G. J., Melchior, L. A., and Panter, A. T. (1998 - 2001). The Measurement Group Knowledge Base on HIV/AIDS Care. On the World Wide Web: http://www.TheMeasurementGroup.com."

Questions or Comments: Contact The Measurement Group.

Use of Knowledge Base Information: Acceptable Uses and Limitations.

Collaborators from Participating Projects: Cooperative Agreement Steering Committee 1999

Participating Projects: This Knowledge Base is based on the service delivery experiences of 27 Cooperative Agreement Projects on Innovative Models of HIV/AIDS Care. These projects and the Evaluation and Dissemination Center which produced this Knowledge Base were funded by the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB) as Special Projects of National Significance (SPNS) between 1994 and 1999. Click the Model Programs button above for descriptions of the projects that contributed to this specific Knowledge Item, a list of key staff, and project grant numbers.

Why This Evaluation was Conducted: Editorial.

More Information: Design of this Knowledge Base.

Recommended Citation Format for Web Materials: American Psychological Association Publication Manual Section, Revised 2001.

Work on the Knowledge Base and the cross-cutting evaluation was supported in part by Grant Number 5 U90 HA 00030-05 from the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau's (HAB) Special Projects of National Significance (SPNS). The contents of this Knowledge Base are solely the responsibility of The Measurement Group and do not necessarily represent the official views of HRSA or HRSA/HAB's Special Projects of National Significance nor may they represent the positions of the individual grantees whose projects are included in the cross-cutting evaluation.



© Copyright 2005 by The Measurement Group LLC. All rights reserved.